Mild Toxicity and Favorable Prognosis of High–Dose and Extended Involved-Field Intensity-Modulated Radiotherapy for Patients With Early-Stage Nasal NK/T-Cell Lymphoma-Reference-Cited by-同舟云学术

Mild Toxicity and Favorable Prognosis of High–Dose and Extended Involved-Field Intensity-Modulated Radiotherapy for Patients With Early-Stage Nasal NK/T-Cell Lymphoma

Published:2012-03 Issue:3 Volume:82 Page:1115-1121
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Wang Hua,Li Ye-Xiong,Wang Wei-Hu,Jin Jing,Dai Jian-Rong,Wang Shu-Lian,Liu Yue-Ping,Song Yong-Wen,Wang Zhao-Yang,Liu Qing-Feng,Fang Hui,Qi Shu-Nan,Liu Xin-Fan,Yu Zi-Hao

Funder

National Natural Science Foundation of China

Ministry of Health of the People's Republic of China

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference32 articles.

1. Clinicopathologic study of 963 cases of mature T-cell and natural killer/T-cell lymphoma with respect to 2008 WHO classification of lymphoid neoplasms;Liang;Chin J Pathol,2010

2. Extranodal natural killer T-cell lymphoma, nasal-type: A prognostic model from a retrospective multicenter study;Lee;J Clin Oncol,2006

3. Clinical heterogeneity of extranodal NK/T-cell lymphoma, nasal type: A national survey of the Korean Cancer Study Group;Kim;Ann Oncol,2008

4. Clinical differences between nasal and extranasal NK/T-cell lymphoma: A study of 136 cases from the International Peripheral T-cell Lymphoma Project;Au;Blood,2009

5. Radiotherapy as primary treatment for stage IE and IIE nasal natural killer/T-cell lymphoma;Li;J Clin Oncol,2006

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Can the radiation dose be safely reduced in the treatment of nk/T cell lymphoma?;Leukemia & Lymphoma;2024-07-05

2. Extranodal nasal-type NK/T lymphoma treated with chemotherapy and radiotherapy: case series from a European tertiary referral center and review of the literature;Strahlentherapie und Onkologie;2023-11-09

3. Phase 2 Clinical Trial of Simultaneous Boost Intensity Modulated Radiation Therapy With 3 Dose Gradients in Patients With Stage I-II Nasal Type Natural Killer/T-Cell Lymphoma: Long-Term Outcomes of Survival and Quality of Life;International Journal of Radiation Oncology*Biology*Physics;2023-11

4. Feasibility of low-dose radiotherapy for patients with stage I/II extranodal NK-/T-cell lymphoma, nasal type achieving complete response after l-asparaginase-containing chemotherapy;Clinical and Translational Radiation Oncology;2023-01

5. Effects of gross tumor volume and radiation dose on survival and locoregional recurrence in early-stage extranodal NK/T-cell lymphoma treated with intensity-modulated radiation therapy;Journal of Cancer Research and Clinical Oncology;2022-11-14